News

Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple ...
While presenting the data at this year's American Society of Clinical Oncology (ASCO) annual meeting, Peter Voorhees, MD, of ...
Like many closely-knit mothers and daughters, Noreen and Anne Hennessy love nothing more than hitting the shops together at ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. Twenty-two years later, ...
Veteran 95.5 WSB Atlanta radio host Scott Slade has shared a positive update on his recovery from multiple myeloma, nearly a month after undergoing a stem cell transplant.
Gordon was diagnosed in 2013 with multiple myeloma, a cancer of the blood plasma. Seven years after his initial chemotherapy and stem cell transplant, it came back. "Myeloma is a difficult disease ...
The company’s lead program, GPC-100, is being evaluated for its ability to improve stem cell mobilization in multiple myeloma, sickle cell disease, and in support of cell and gene therapy.
A multiple sclerosis patient who received a stem cell transplant in Denver is now doing well and hopes to spread awareness about the treatment option. Skip to content FOX31 Denver ...
Standard treatment for multiple myeloma involves multi-drug therapy. Most patients receive a combination of four drugs; if they’re below age 75, they’re considered for a stem cell transplant after the ...
A multiple myeloma cell therapy has encouraging results analysts say could make it best in its class and a gene-editing therapy is showing early promise in sickle cell disease. Here’s a recap of ...